Triple negative breast cancer (TNBC) is a subtype of breast cancer that shares with the basal-like group many of its characteristics and GEP markers, including expression of basal cytokeratins 5/6, 14, and 17, as well as the epidermal growth factor receptor (EGFR) and vimentin [20]. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.